[Edaily Reporter Kwon Oh Seok ] Hyper Corporation(065650), which had been pursuing a rights offering followed by a public offering of unsubscribed shares to raise operating funds, announced on the 27th that it is withdrawing its capital increase plan. The company explained, “During the public offering process, the Financial Supervisory Service requested corrections and additional reviews, which prolonged the capital increase process. We determined that this could cause confusion among existing shareholders and new investors.” Previously, the company had announced plans for a capital increase of approximately 20 billion won.
Disclosure Plus
Hyper Corporation Withdraws Plan for a Paid-in Capital Increase
Economy
Corporation
IT·Science
Economy
Shifting from Short-Term to Medium- and Long-Term... Appeal of Commercial Paper as a Funding Source Plummets
Fluctuations in credit spreads serve as an indicator of investor sentiment and capital flows in the corporate bond market. “Credit Signal” provides an intuitive analysis of the market’s overall trends…
Corporation
Jeong Yong-jin Starts by Replacing E-MART Co., Ltd.’s CEO… Appoints Entire Executive Team in Their 40s
Shinsegae Co.,Ltd Chairman Chung Yong-jin is returning to the forefront of management at E-MART Co., Ltd.(139480). Unlike in 2013, when he stepped down as a registered director and entrusted the busin…
IT·Science
HANALL BIOPHARMA CO.,LTD’s ‘Batoclimab’ Receives First New Drug Approval in China Nine Years After Technology Export
“Batoclimab,” a treatment for autoimmune diseases developed by HANALL BIOPHARMA CO.,LTD(009420), has received new drug approval in China. This comes approximately nine years after the company licensed…